XML 27 R16.htm IDEA: XBRL DOCUMENT
v3.21.2

GOODWILL AND INTANGIBLE ASSETS | 9 Months Ended
--- | ---
Sep. 25, 2021
Goodwill and Intangible Assets Disclosure [Abstract] |
GOODWILL AND INTANGIBLE ASSETS | GOODWILL AND INTANGIBLE ASSETS Goodwill The following table provides a rollforward of the Company’s goodwill:
|  |  | Adjustments to Goodwill |  |
| December 26, 2020 |  | Acquisitions |  |  |  | Foreign Exchange |  | Other 1 |  | September 25, 2021
| (in thousands)
RMS | $ | 287,759 |  |  | $ | — |  |  |  |  | $ | (29) |  |  | $ | (6,876) |  |  | $ | 280,854 |
DSA | 1,378,130 |  |  | 123,092 |  |  |  |  | (11,436) |  |  | — |  |  | $ | 1,489,786 |
Manufacturing | 143,279 |  |  | 851,614 |  |  |  |  | (2,610) |  |  | (26,601) |  |  | $ | 965,682 |
Goodwill | $ | 1,809,168 |  |  | $ | 974,706 |  |  |  |  | $ | (14,075) |  |  | $ | (33,477) |  |  | $ | 2,736,322 |
The increase in goodwill during the nine months ended September 25, 2021 related primarily to the acquisitions of Cognate and Vigene in the Manufacturing reportable segment and Distributed Bio and Retrogenix in the DSA reportable segment. 1 On October 12, 2021, the Company divested two businesses (see Note 18 “Subsequent Events”) and reclassified the related goodwill to assets held for sale as of September 25, 2021. Intangible Assets, Net The following table displays intangible assets, net by major class:
| September 25, 2021 |  | December 26, 2020
| Gross |  | Accumulated Amortization |  | Net |  | Gross |  | Accumulated Amortization |  | Net
| (in thousands)
Backlog | $ | 11,874 |  |  | $ | (8,019) |  |  | $ | 3,855 |  |  | $ | 29,233 |  |  | $ | (29,233) |  |  | $ | — |
Technology | 137,753 |  |  | (92,884) |  |  | 44,869 |  |  | 130,907 |  |  | (81,305) |  |  | 49,602 |
Trademarks and trade names | 13,188 |  |  | (3,074) |  |  | 10,114 |  |  | 15,870 |  |  | (5,648) |  |  | 10,222 |
Other | 35,331 |  |  | (6,895) |  |  | 28,436 |  |  | 20,903 |  |  | (14,633) |  |  | 6,270 |
Other intangible assets | 198,146 |  |  | (110,872) |  |  | 87,274 |  |  | 196,913 |  |  | (130,819) |  |  | 66,094 |
Client relationships | 1,497,255 |  |  | (484,649) |  |  | 1,012,606 |  |  | 1,137,331 |  |  | (415,826) |  |  | 721,505 |
Intangible assets | $ | 1,695,401 |  |  | $ | (595,521) |  |  | $ | 1,099,880 |  |  | $ | 1,334,244 |  |  | $ | (546,645) |  |  | $ | 787,599 |
The increase in intangible assets, net during the nine months ended September 25, 2021 related primarily to the acquisitions of Cognate, Distributed Bio, Retrogenix, and Vigene. Certain intangibles assets were reclassified to assets held for sale as of September 25, 2021 in connection with two divestitures that occurred on October 12, 2021. See Note 18 “Subsequent Events”

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI http://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration